Minute Insight: Restore3d Purchases Conformis, Creating ‘One Stop Shop’ For Personalized Implants

The two companies will merge following a cash-for-shares offer from restore3d being accepted by Conformis’ board.

Minute Insight
• Source: Citeline/Alamy

Restor3d has agreed to pay approximately $17m to acquire Conformis, its competitor in the 3D-printed orthopedics market.

It will purchase all outstanding common stock shares of Conformis at a price of $2.27 each. This is a 96%...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Minute Insights

More from Medtech Insight

Stealth Mode AI Imaging Startup Faction Imaging Raises $10M

 

Faction Imaging has come out of stealth mode following six years of research and development studying medical imaging workflows in India, Japan and the US.

Remepy To Embed AI In Next-Gen Digital Therapeutics For Personalized Neuroimmune Modulation

 
• By 

Remepy is exploring two potential regulatory pathways to support this strategy. The first is a combination product pathway that would formally integrate software and drug into a single therapeutic entity. The second is the FDA’s Prescription Drug Use-Related Software (PDURS) pathway.

Execs On The Move: June 9–13, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.